Teva Pharmaceuticals USA Inc. recalls Actavis — Metformin Hydrochloride Extended-Release Tablets, USP 500mg and 750mg
- Recall date
- June 5, 2020
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Teva Pharmaceuticals USA Inc., Actavis
Why it was recalled
Due to detection of N-Nitrosodimethylamine (NDMA) — Ingredient Level
What was recalled
Metformin Hydrochloride Extended-Release Tablets, USP 500mg and 750mg
Read the official recall notice →
Get recall alerts
Free email alert whenever Teva Pharmaceuticals USA Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Teva Pharmaceuticals USA Inc., Actavis